China's Nanjing tightens restrictive measures to stem spike in COVID-19 infections
NANJING -- Nanjing, capital of east China's Jiangsu province, has tightened the epidemic prevention and control measures after the recent spike in COVID-19 infections in the city.
Among the measures, all retail pharmacies in the city suspended selling antipyretic, cough, antiviral and antibiotic medicine to citizens, according to the municipal epidemic prevention and control headquarters.
The city's major hospitals, excluding emergency departments and fever clinics, were urged to implement appointment registration, while closed venues and offline training services also suspended business.
Nanjing, a mega-city with a population of more than 9.3 million, has added more than 100 locally transmitted COVID-19 cases since a few airport workers tested positive for coronavirus last week.
- Plan to boost eye care services by 2030
- China sees wider healthcare access as system continues to grow
- China moves to further improve family doctor services
- China targets better health for all by 2030
- China targets average life expectancy of 80 by 2030 in new five-year health plan
- The number of assisted reproductive institutions reaches 645 in China


